NS HEALTH VITACAPS LTD

Active London

Other human health activities

2 employees website.com
Lifestyle and entertainment Other human health activities
N

NS HEALTH VITACAPS LTD

Other human health activities

Founded 2 Aug 2023 Active London, England 2 employees website.com
Lifestyle and entertainment Other human health activities
Accounts Submitted 25 Feb 2026 Next due 31 Dec 2025 5 months overdue
Confirmation Submitted 24 Sept 2025 Next due 1 Oct 2026 4 months remaining
Net assets £-135K £184K 2024 year on year
Total assets £67K £147 2024 year on year
Total Liabilities £201K £184K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

5th Floor 36 St. James's Street London SW1A 1JD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NS HEALTH VITACAPS LTD (15045562), an active lifestyle and entertainment company based in London, England. Incorporated 2 Aug 2023. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

N/A

Decreased by £55.55k (-100%)

Net Assets

-£134.61k

Decreased by £183.98k (-373%)

Total Liabilities

£201.13k

Increased by £183.83k (+1063%)

Turnover

N/A

Employees

2

Decreased by 1 (-33%)

Debt Ratio

302%

Increased by 276 (+1062%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 90 Shares £86k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
6 Oct 202390£86k£950

Officers

Officers

2 active 1 resigned
Status
Ekinci, Asya IlaydaDirectorTurkishEngland3217 Nov 2023Active
Rudmann, Scott William, Mr.DirectorBritishEngland562 Aug 2023Active

Shareholders

Shareholders (6)

Scott Rudmann
82.4%
899
Asya Ilayda Ekinci
12.0%
131

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Scott William Rudmann

British

Active
Notified 2 Aug 2023
Residence England
DOB January 1970
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Antonia Pruy

Ceased 3 Sept 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Mar 2026GazetteGazette Filings Brought Up To Date
3 Mar 2026GazetteGazette Notice Compulsory
25 Feb 2026AccountsAnnual accounts made up to 31 Dec 2024
3 Oct 2025IncorporationMemorandum Articles
2 Oct 2025CapitalCapital Alter Shares Subdivision
4 Mar 2026 Gazette

Gazette Filings Brought Up To Date

3 Mar 2026 Gazette

Gazette Notice Compulsory

25 Feb 2026 Accounts

Annual accounts made up to 31 Dec 2024

3 Oct 2025 Incorporation

Memorandum Articles

2 Oct 2025 Capital

Capital Alter Shares Subdivision

Recent Activity

Latest Activity

Gazette Filings Brought Up To Date

2 months ago on 4 Mar 2026

Gazette Notice Compulsory

2 months ago on 3 Mar 2026

Annual accounts made up to 31 Dec 2024

2 months ago on 25 Feb 2026

Memorandum Articles

7 months ago on 3 Oct 2025

Capital Alter Shares Subdivision

7 months ago on 2 Oct 2025